Literature DB >> 23211185

Point-of-care INR coagulometers for self-management of oral anticoagulation: primary care diagnostic technology update.

Annette Plüddemann1, Matthew Thompson, Jane Wolstenholme, Christopher P Price, Carl Heneghan.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23211185      PMCID: PMC3481522          DOI: 10.3399/bjgp12X658476

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  13 in total

Review 1.  Precision and accuracy of point-of-care testing coagulometers used for self-testing and self-management of oral anticoagulation therapy.

Authors:  T D Christensen; T B Larsen
Journal:  J Thromb Haemost       Date:  2012-02       Impact factor: 5.824

2.  Economic evaluation of the use of point-of-care devices in patients with long term oral anticoagulation.

Authors:  Sophie Gerkens; Jeannine Gailly; Caroline Obyn; Stephan Devriese; Irina Cleemput
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

3.  Self management of oral anticoagulation: randomised trial.

Authors:  D A Fitzmaurice; E T Murray; D McCahon; R Holder; J P Raftery; S Hussain; H Sandhar; F D R Hobbs
Journal:  BMJ       Date:  2005-10-10

Review 4.  Self-monitoring and self-management of oral anticoagulation.

Authors:  Josep M Garcia-Alamino; Alison M Ward; Pablo Alonso-Coello; Rafael Perera; Clare Bankhead; David Fitzmaurice; Carl J Heneghan
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

5.  Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management.

Authors:  Siegmund Braun; Herbert Watzke; J Michael Hasenkam; Michael Schwab; Tanja Wolf; Clemens Dovifat; Heinz Völler
Journal:  Thromb Haemost       Date:  2007-02       Impact factor: 5.249

6.  Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial.

Authors:  Andrea Siebenhofer; Ivo Rakovac; Caroline Kleespies; Brigitte Piso; Ulrike Didjurgeit
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

7.  Self- versus conventional management of oral anticoagulant therapy: effects on INR variability and coumarin dose in a randomized controlled trial.

Authors:  Thomas Decker Christensen; Marianne Maegaard; Henrik Toft Sørensen; Vibeke Elisabeth Hjortdal; J Michael Hasenkam
Journal:  Am J Cardiovasc Drugs       Date:  2007       Impact factor: 3.571

Review 8.  Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling.

Authors:  M Connock; C Stevens; A Fry-Smith; S Jowett; D Fitzmaurice; D Moore; F Song
Journal:  Health Technol Assess       Date:  2007-10       Impact factor: 4.014

9.  Self-monitoring of oral anticoagulation: does it work outside trial conditions?

Authors:  C Gardiner; I Longair; M A Pescott; H Erwin; J Hills; S J Machin; H Cohen
Journal:  J Clin Pathol       Date:  2009-02       Impact factor: 3.411

10.  Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01
View more
  3 in total

1.  Security and cost comparison of INR self-testing and conventional hospital INR testing in patients with mechanical heart valve replacement.

Authors:  Qiu-lin Chen; Li Dong; Yi-jun Dong; Shu-lin Zhao; Bo Fu; Yu-qing Wang; Hong Jiang
Journal:  J Cardiothorac Surg       Date:  2015-01-16       Impact factor: 1.637

2.  Supporting patients to self-monitor their oral anticoagulation therapy: recommendations based on a qualitative study of patients' experiences.

Authors:  Alice Tompson; Carl Heneghan; David Fitzmaurice; Stephen Sutton; Sian Harrison; Alison Ward
Journal:  Br J Gen Pract       Date:  2015-06-15       Impact factor: 5.386

3.  MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury.

Authors:  A D Bastiaan Vliegenthart; Cécile Berends; Carmelita M J Potter; Maiwenn Kersaudy-Kerhoas; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2017-04-05       Impact factor: 3.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.